2 companies won 4 federal contract awards worth $1.2 million for in-vitro diagnostic substance manufacturing (NAICS 325413) in New York in our record between June 2026 and October 2026. The largest are Biomerieux Inc, Siemens Healthcare Diagnostics Inc.
2
companies
4
contract awards
$1.2 million
obligated
| # | Company | UEI | Awards | Obligated | Latest award |
|---|---|---|---|---|---|
| 1 | Biomerieux Inc | HCNVCMEG9NL6 | 3 | $996,401 | 2026-10-05 |
| 2 | Siemens Healthcare Diagnostics Inc. | GC14SNHB3JN1 | 1 | $175,000 | 2026-06-12 |
| Company | Agency | Obligated | Signed | Record |
|---|---|---|---|---|
| Biomerieux Inc | Department of Veterans Affairs | $397,395 | 2026-10-05 | 36C24227N0056 on USAspending.gov (opens in a new tab) |
| Biomerieux Inc | Department of Veterans Affairs | $359,216 | 2026-10-05 | 36C24227N0057 on USAspending.gov (opens in a new tab) |
| Biomerieux Inc | Department of Veterans Affairs | $239,790 | 2026-10-05 | 36C24227N0058 on USAspending.gov (opens in a new tab) |
| Department of the Navy |
| $175,000 |
| 2026-06-12 |
| N6854626FA036 on USAspending.gov (opens in a new tab) |
From USAspending.gov. Award totals are federal obligations, not company revenue.